PublisherThe University of Arizona.
RightsCopyright © is held by the author. Digital access to this material is made possible by the University Libraries, University of Arizona. Further transmission, reproduction or presentation (such as public display or performance) of protected items is prohibited except with permission of the author.
AbstractThe pharmaceutical industry is a potentially powerful but untapped industry in Southern Arizona. One such company in this industry is Topical Technologies, which develops topical solutions to treat skin cancer, and was founded by University of Arizona Cancer Center researchers. We conducted our primary research in the form of one-on-one interviews with diverse experts in a variety of fields; Dr. Robert Dorr, Co-Founder of Topical Technologies, Dr. Steve Stratton, Associate Professor of Medicine at AZCC, Robert Morrison, the Executive Director of the Desert Angels, Marie Wesselhoft, former Director of the Arizona Center for Innovation, and Dr. Debra Hanna, Associate Director of C-Path. We also conducted secondary research into the pharmaceutical industry. After conducting our research and analyzing the data, we formulated several recommendations to Tech Launch Arizona including: *Fostering relationships between the University leadership, business school, and BIO5 Institute *Forming long-term relationships with corporations *Building a venture portfolio that invests in multiple industries *Partnering with the Critical Path Institute We believe these recommendations will help create a more efficient environment for pharmaceutical companies to be successful.
Degree ProgramHonors College